The tweet was deleted by the author.
But we saved everything 🙂.
Bicara Therapeutics Inc. has named Jeremy Bender, Ph.D., MBA, and Christy Oliger to its Board of Directors, strengthening its leadership with more than 50 years of combined biopharma experience.
The company stated that the new appointments will help guide its strategy and execution as it enters a new phase of growth. Bender and Oliger are recognized as established leaders in the biopharmaceutical sector. The full announcement can be found on Bicara Therapeutics Inc.'s website.
View post on X Loading...